Claims for Patent: 5,955,109
✉ Email this page to a colleague
Summary for Patent: 5,955,109
Title: | Methods and compositions for topical delivery of retinoic acid |
Abstract: | Retinoic acid compositions intended for topical application are incorporated in novel formulations in which they are retained as impregnants inside the pores of porous solid particles or microspheres. The pores form a continuous network open to the exterior of the particles, permitting outward diffusion of the retinoic acid impregnant at a controlled rate depending on the pore size. The impregnated particles are prepared by impregnation of preformed particles with the retinoic acid. |
Inventor(s): | Won; Richard (Palo Alto, CA), Katz; Martin A. (Menlo Park, CA), Cheng; Chung H. (San Jose, CA), Nacht; Sergio (Los Altos, CA) |
Assignee: | Advanced Polymer Systems, Inc. (Redwood City, CA) |
Application Number: | 08/079,220 |
Patent Claims: |
1. A topical composition for the delivery of retinoic acid to the skin, the composition comprising:
(a) solid particles composed of a cross-linked copolymer of monoethylenically unsaturated monomers and polyethylenically unsaturated monomers free from reactive functionalities and having a cross-linking density from 20% to 80%, wherein said particles contain a continuous noncollapsible network of pores open to the exterior of said particles, are spherical in shape, and have an average diameter of about 1 micron to about 100 microns, a total pore volume of about 0.01 cc/g to about 4.0 cc/g, a surface area of about 1 m.sup.2 /g to about 500 m.sup.2 /g, and an average pore diameter of about 0.001 micron to about 3.0 microns, and (b) an impregnant comprising retinoic acid retained inside said pores in an amount effective to promote skin repair, wherein retention of said retinoic acid inside said pores reduces irritancy of the composition when compared to application of the same amount of free retinoic acid without loss of skin repair promotion activity. 2. A topical composition in accordance with claim 1 in which said retinoic acid is retained inside said pores as a solid. 3. A topical composition in accordance with claim 1 in which said retinoic acid is retained inside said pores in a solvent selected from the group consisting of ethers, esters, alcohols, aromatics, and alkanes. 4. A topical composition in accordance with claim 1 in which said solid particles have an average diameter of about 10 microns to about 40 microns, a total pore volume of about 0.1 cc/g to about 2.0 cc/g, a surface area of about 20 m.sup.2 /g to about 200 m.sup.2 /g, and an average pore diameter of about 0.003 micron to about 1.0 micron. 5. A topical composition in accordance with claim 1 in which said solid particles are composed of a cross-linked copolymer of styrene and divinylbenzene. 6. A topical composition in accordance with claim 1 in which said solid particles are composed of a cross-linked copolymer of methyl methacrylate and ethylene glycol dimethacrylate. 7. A topical composition in accordance with claim 1 in which said solid particles are composed of a cross-linked copolymer of 4-vinylpyridine and ethylene glycol dimethacrylate. 8. A topical composition in accordance with claim 1 in which said solid particles are combined with a vehicle to form a composition selected from the group consisting of liniments, gels, lotions, and ointments. 9. A topical composition in accordance with claim 1 in which said impregnant comprises about 1% to about 20% by weight of the total weight of said solid particles and said impregnant. 10. A topical composition in accordance with claim 9 in which said impregnant comprises about 1% to about 2.5 by weight of the total weight of said solid particles and said impregnant. 11. A method for applying retinoic acid to the skin, the method comprising applying to the skin a topical composition comprising: (a) solid particles composed of a cross-linked copolymer of monoethylenically unsaturated monomers and polyethylenically unsaturated monomers free from reactive functionalities and having a cross-linking density from 20% to 80%, wherein said particles contain a continuous noncollapsible network of pores open to the exterior of said particles, are spherical in shape and have an average diameter of about 1 micron to about 100 microns, a total pore volume of about 0.01 cc/g to about 4.0 cc/g, a surface area of about 1 m.sup.2 /g to about 500 m.sup.2 /g, and an average pore diameter of about 0.001 micron to about 3.0 microns, and (b) an impregnant comprising retinoic acid retained inside said pores in an amount effective to promote skin repair, wherein retention of said retinoic acid inside said pores reduces irritancy of the composition when compared to application of the same amount of free retinoic acid without loss of skin repair promotion activity. 12. A method in accordance with claim 11 in which said retinoic acid is retained inside said pores as a solid. 13. A method in accordance with claim 11 in which said retinoic acid is retained inside said pores in a solvent selected from the group consisting of ethers, esters, alcohols, aromatics, and alkanes. 14. A method in accordance with claim 11 in which said solid particles have an average diameter of about 10 microns to about 40 microns a total pore volume of about 0.1 cc/g to about 2.0 cc/g, a surface area of about 20 m.sup.2 /g to about 200 m.sup.2 /g, and an average pore diameter of about 0.003 micron to about 10 micron. 15. A method in accordance with claim 11 in which said solid particles are composed of a cross-linked copolymer of styrene and divinylbenzene. 16. A method in accordance with claim 11 in which said solid particles are composed of a cross-linked copolymer of methyl methacrylate and ethylene glycol dimethacrylate. 17. A method in accordance with claim 11 in which said solid particles are composed of a cross-linked copolymer of 4-vinylpyridine and ethylene glycol dimethacrylate. 18. A method in accordance with claim 11 in which said solid particles are combined with a vehicle to form a composition selected from the group consisting of liniments, gels, lotions, and ointments. 19. A method in accordance with claim 11 in which said impregnant comprises about 1% to about 20% by weight of the total weight of said solid particles and said impregnant. 20. A method in accordance with claim 19 in which said impregnant comprises about 1% to about 2.5% by weight of the total weight of said solid particles and said impregnant. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.